1. Home
  2. BLFS

as of 12-05-2025 3:40pm EST

$25.44
$0.39
-1.53%
Stocks Health Care Medical/Dental Instruments Nasdaq

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Chart Type:
Time Range:
Founded: 1987 Country:
United States
United States
Employees: N/A City: BOTHELL
Market Cap: 1.2B IPO Year: 1989
Target Price: $31.50 AVG Volume (30 days): 375.5K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.07 EPS Growth: N/A
52 Week Low/High: $19.10 - $29.62 Next Earning Date: 11-06-2025
Revenue: $100,144,000 Revenue Growth: 87.53%
Revenue Growth (this year): 20.67% Revenue Growth (next year): 14.13%

AI-Powered BLFS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 71.14%
71.14%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)

DE GREEF RODERICK

President and CEO

Sell
BLFS Nov 13, 2025

Avg Cost/Share

$25.33

Shares

31,165

Total Value

$789,409.45

Owned After

389,998

SEC Form 4

DE GREEF RODERICK

President and CEO

Sell
BLFS Nov 12, 2025

Avg Cost/Share

$25.88

Shares

33,418

Total Value

$864,857.84

Owned After

389,998

SEC Form 4

DE GREEF RODERICK

President and CEO

Sell
BLFS Nov 11, 2025

Avg Cost/Share

$26.15

Shares

35,417

Total Value

$926,154.55

Owned After

389,998

SEC Form 4

Sell
BLFS Oct 24, 2025

Avg Cost/Share

$28.99

Shares

1,666

Total Value

$48,297.34

Owned After

44,986

SEC Form 4

DE GREEF RODERICK

President and CEO

Sell
BLFS Oct 22, 2025

Avg Cost/Share

$27.30

Shares

37,795

Total Value

$1,031,803.50

Owned After

389,998

SEC Form 4

Werner Sean

Chief Technology Officer

Sell
BLFS Oct 20, 2025

Avg Cost/Share

$27.82

Shares

275

Total Value

$7,650.50

Owned After

26,037

SEC Form 4

Sell
BLFS Oct 16, 2025

Avg Cost/Share

$0.00

Shares

1,334

Total Value

$0.00

Owned After

44,986

SEC Form 4

Aebersold Sarah

Chief Human Resources Officer

Sell
BLFS Oct 9, 2025

Avg Cost/Share

$27.36

Shares

188

Total Value

$5,143.68

Owned After

77,169

SEC Form 4

Berard Todd

Chief Marketing Officer

Sell
BLFS Oct 9, 2025

Avg Cost/Share

$27.36

Shares

289

Total Value

$7,907.04

Owned After

133,617

SEC Form 4

Foster Karen A.

Chief Quality and Operations

Sell
BLFS Oct 9, 2025

Avg Cost/Share

$27.36

Shares

419

Total Value

$11,463.84

Owned After

193,253

SEC Form 4

Share on Social Networks: